XBiotech
XBIT
60 hedge funds and large institutions have $46.6M invested in XBiotech in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 34 reducing their positions, and 10 closing their positions.
1.89% more ownership
Funds ownership: 13.33% → 15.21% (+1.9%)
0% more funds holding
Funds holding: 60 → 60 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
53% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 34
54% less capital invested
Capital invested by funds: $102M → $46.6M (-$55.6M)
80% less call options, than puts
Call options by funds: $446K | Put options by funds: $2.26M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$4.27M |
| 2 |
Jane Street
New York
|
+$2.31M |
| 3 |
Goldman Sachs
New York
|
+$1.7M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$821K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$775K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$7.5M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$4.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.4M |
| 4 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$3.02M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.4M |
XBIT Hedge Fund Activity: Q1 2020 in Review
60 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q1 2020, worth a combined $46.6M — down 54% from $102M a quarter earlier.
Fund positioning in XBIT was balanced in Q1 2020: 10 funds opened new positions, 10 closed out, 16 added to existing stakes and 34 trimmed.
The largest buyer was Bank of America, adding an estimated $4.27M. The largest seller was BlackRock, cutting an estimated $7.5M.
- 60 institutional investors held XBiotech (XBIT) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $46.6M of XBiotech stock for Q1 2020, down 54% quarter-over-quarter.
- 10 funds opened new XBiotech positions in Q1 2020 and 10 closed out, a net change of 0 holders.
- The largest XBiotech buyer in Q1 2020 was Bank of America, an estimated $4.27M added.
- The largest XBiotech seller in Q1 2020 was BlackRock, an estimated $7.5M sold.
Based on aggregated 13F filings for Q1 2020.